Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BP1001 |
Trade Name | |
Synonyms | Prexigebersen |
Drug Descriptions |
Prexigebersen (BP1001) is a liposome-incorporated antisense oligo targeting the Grb2 mRNA that inhibits Grb2 expression, resulting in growth inhibition in tumor cells (PMID: 29550383). |
DrugClasses | |
CAS Registry Number | 202484-91-1 |
NCIT ID | C91736 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BP1001 | BP1001 | 0 | 0 |
BP1001 + Cytarabine | BP1001 Cytarabine | 0 | 1 |
BP1001 + Dasatinib | BP1001 Dasatinib | 0 | 1 |